In contrast of TNBC, this analysis showed that breast cancer with high ERBB4 expression had better prognosis than that with low ERBB4 expression (p = 0.003), as like as previous research presenting that ERBB4 overexpression was good prognostic indicator of ER positive and/or HER2 positive breast cancer. Here, ERBB2 is linked to breast cancer.